HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,388,416 | +14.7% | 60,152 | +9.0% | 0.03% | +13.8% |
Q2 2023 | $4,699,302 | -7.9% | 55,195 | -10.4% | 0.03% | -6.5% |
Q1 2023 | $5,099,800 | +8.9% | 61,629 | +3.5% | 0.03% | +19.2% |
Q4 2022 | $4,681,799 | -21.9% | 59,527 | -26.5% | 0.03% | -13.3% |
Q3 2022 | $5,995,000 | +13.5% | 80,981 | -0.1% | 0.03% | +36.4% |
Q2 2022 | $5,283,000 | +13.7% | 81,045 | +10.3% | 0.02% | +15.8% |
Q1 2022 | $4,646,000 | +56.5% | 73,493 | +31.3% | 0.02% | +11.8% |
Q4 2021 | $2,969,000 | -11.8% | 55,975 | +17.4% | 0.02% | -5.6% |
Q3 2021 | $3,365,000 | -2.7% | 47,669 | -8.2% | 0.02% | -18.2% |
Q2 2021 | $3,459,000 | – | 51,905 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |